Melo-Marques I

References (6)

Title : Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs - Dias_2025_Antioxidants.(Basel)_14_
Author(s) : Dias I , Emmanuel M , Vogt P , Guerreiro-Oliveira C , Melo-Marques I , Cardoso SM , Guedes RC , Chaves S , Santos MA
Ref : Antioxidants (Basel) , 14 : , 2025
Abstract :
PubMedSearch : Dias_2025_Antioxidants.(Basel)_14_
PubMedID: 40867820

Title : Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs - Dias_2025_Antioxidants.(Basel)_14_
Author(s) : Dias I , Emmanuel M , Vogt P , Guerreiro-Oliveira C , Melo-Marques I , Cardoso SM , Guedes RC , Chaves S , Santos MA
Ref : Antioxidants (Basel) , 14 : , 2025
Abstract :
PubMedSearch : Dias_2025_Antioxidants.(Basel)_14_
PubMedID: 40867820

Title : Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs - Dias_2025_Antioxidants.(Basel)_14_
Author(s) : Dias I , Emmanuel M , Vogt P , Guerreiro-Oliveira C , Melo-Marques I , Cardoso SM , Guedes RC , Chaves S , Santos MA
Ref : Antioxidants (Basel) , 14 : , 2025
Abstract :
PubMedSearch : Dias_2025_Antioxidants.(Basel)_14_
PubMedID: 40867820

Title : New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease - Bon_2024_Pharmaceutics_16_
Author(s) : Bon L , Banas A , Dias I , Melo-Marques I , Cardoso SM , Chaves S , Santos MA
Ref : Pharmaceutics , 16 : , 2024
Abstract :
PubMedSearch : Bon_2024_Pharmaceutics_16_
PubMedID: 38399339

Title : New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease - Bon_2024_Pharmaceutics_16_
Author(s) : Bon L , Banas A , Dias I , Melo-Marques I , Cardoso SM , Chaves S , Santos MA
Ref : Pharmaceutics , 16 : , 2024
Abstract :
PubMedSearch : Bon_2024_Pharmaceutics_16_
PubMedID: 38399339

Title : New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease - Bon_2024_Pharmaceutics_16_
Author(s) : Bon L , Banas A , Dias I , Melo-Marques I , Cardoso SM , Chaves S , Santos MA
Ref : Pharmaceutics , 16 : , 2024
Abstract :
PubMedSearch : Bon_2024_Pharmaceutics_16_
PubMedID: 38399339